Intrathecal morphine dose optimization in robotic-assisted laparoscopic hysterectomy: a dual-center cohort study
Journal of Robotic Surgery · 12.05.2026 · 20 (1)
DOI: 10.1007/s11701-026-03445-y ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Robotic Surgery, online erschienen am 12.05.2026. Verfasst von Andrea Russo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Anaesthesia, and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Morphine, Hysterectomy, Robotic Surgical Procedures, Postoperative Pain. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Udine.
Abstract (Originalsprache)
Background
Optimized perioperative analgesia is a critical component of Enhanced Recovery After Surgery (ERAS) pathways in robotic-assisted laparoscopic hysterectomy (RALH). In high-volume robotic programs, predictable pain control may influence early mobilization, postoperative stability, and discharge planning. This study evaluated the analgesic efficacy and safety of two low-dose intrathecal morphine (ITM) regimens (0.10 mg vs. 0.15 mg) in patients undergoing RALH.
Methods
We conducted a retrospective dual-center cohort study including 100 women who received spinal anesthesia with 0.10–0.15 mg of preservative-free intrathecal morphine, with or without levobupivacaine, prior to general anesthesia for RALH. Postoperative pain was assessed using the Visual Analog Scale (VAS) at three time points (PACU arrival, PACU discharge, and 24 h postoperatively). Rescue opioid use, hemodynamic events, postoperative nausea and vomiting (PONV), pruritus, and recovery parameters (Alderete Score) were recorded. Comparative analyses were performed between the two ITM dose groups.
Results
Pain scores remained consistently low across all time points (median VAS = 0; p = 0.302), with rescue analgesia required in 7% of patients ( n = 7/100). Compared with the 0.10 mg group, the 0.15 mg group demonstrated significantly lower pain scores and reduced supplemental opioid requirements. Higher rates of pruritus, PONV, and hypotensive episodes were observed in the 0.10 mg group. No cases of respiratory depression or prolonged PACU stay were recorded. Median Alderete Scores were consistently optimal (10/10), indicating stable postoperative recovery.
Conclusion
Low-dose intrathecal morphine provides effective, opioid-sparing, and motor-preserving analgesia in robotic-assisted laparoscopic hysterectomy. In this cohort, the 0.15 mg regimen was associated with improved analgesic balance without an increase in clinically significant adverse events. Within ERAS-based robotic pathways, optimized intrathecal morphine dosing may support predictable recovery and perioperative stability. Observational design precludes causal inference. Prospective randomized studies are warranted to confirm these findings.
Trial registration
The Ethics Committee approved the study (Protocol ID 3307/2020) on July 6th, 2020, and it was registered in clinicaltrial.gov (NCT07169604).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency, Anaesthesia, and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Pediatric Gynecology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
- Gynecology and Obstetrics Department, Azienda USL Toscana Centro, Santa Maria Annunziata Hospital, Florence, Italy.
- Department of Biotechnological Basic Science, Intensive and Perioperative Medicine, Catholic University of the Sacred Heart, Rome, Italy.
- Clinic of Obstetrics and Gynecology, Santa Maria Della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
- Gynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, 00168, Italy.
Förderung
- Università degli Studi di Udine
Zitieren
APA
Russo, A., Perelli, F., Aceto, P., Arcieri, M., Bernardini, F., Pregnolato, S., Moroni, R., Dogareschi, T., Meroi, F., Costantini, B., Gallotta, V., Fanfani, F., Driul, L., Fagotti, A., Bove, T., Restaino, S., Antonelli, M., & Vizzielli, G. (2026). Intrathecal morphine dose optimization in robotic-assisted laparoscopic hysterectomy: a dual-center cohort study. Journal of Robotic Surgery, 20(1). https://doi.org/10.1007/s11701-026-03445-y
Vancouver
Russo A, Perelli F, Aceto P, Arcieri M, Bernardini F, Pregnolato S, et al. Intrathecal morphine dose optimization in robotic-assisted laparoscopic hysterectomy: a dual-center cohort study. Journal of Robotic Surgery. 2026;20(1). doi:10.1007/s11701-026-03445-y
BibTeX
@article{Russo2026,
author = {Russo, Andrea and Perelli, Federica and Aceto, Paola and Arcieri, Martina and Bernardini, Federica and Pregnolato, Sara and Moroni, Rossana and Dogareschi, Teresa and Meroi, Francesco and Costantini, Barbara and Gallotta, Valerio and Fanfani, Francesco and Driul, Lorenza and Fagotti, Anna and Bove, Tiziana and Restaino, Stefano and Antonelli, Massimo and Vizzielli, Giuseppe},
title = {Intrathecal morphine dose optimization in robotic-assisted laparoscopic hysterectomy: a dual-center cohort study},
journal = {Journal of Robotic Surgery},
year = {2026},
volume = {20},
number = {1},
doi = {10.1007/s11701-026-03445-y}
}
EUVIMED